Plasma morphine concentrations during chronic oral administration in patients with cancer pain

作者: Palle B. Neumann , Hans Henriksen , Nina Grosman , Christian Broen Christensen

DOI: 10.1016/0304-3959(82)90014-8

关键词:

摘要: Abstract Plasma concentrations of morphine were studied in 16 patients with chronic pain due to advanced cancer, treated regular doses chloride by the oral route. Doses ranged from 20 125 mg every 4 h and a significant, positive, linear correlation was found between dose (range 0.22–3.01 mg/kg) mean plasma concentration 22–364 ng/ml). The profile curve is described be subject considerable, individual variation. present investigation supports experience that good relief can obtained, if requirements as interval are taken into consideration.

参考文章(8)
J. G. Ofiesh, B. M. Mount, R. Melzack, The Brompton mixture: effects on pain in cancer patients Canadian Medical Association Journal. ,vol. 115, pp. 125- 129 ,(1976)
I. Ajemian, J. F. Scott, B. M. Mount, Use of the Brompton mixture in treating the chronic pain of malignant disease. Canadian Medical Association Journal. ,vol. 115, pp. 122- 124 ,(1976)
GW Aherne, EM Piall, RG Twycross, Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphate. British Journal of Clinical Pharmacology. ,vol. 8, pp. 577- 580 ,(1979) , 10.1111/J.1365-2125.1979.TB01047.X
Robert F Kaiko, Age and morphine analgesia in cancer patients with postoperative pain. Clinical Pharmacology & Therapeutics. ,vol. 28, pp. 823- 826 ,(1980) , 10.1038/CLPT.1980.241
S. Fred Brunk, Margrieta Delle, Morphine metabolism in man. Clinical Pharmacology & Therapeutics. ,vol. 16, pp. 51- 57 ,(1974) , 10.1002/CPT1974161PART151
J W Findlay, R F Butz, R M Welch, Specific radioimmunoassays for codeine and morphine. Metabolism of codeine to morphine in the rat. Research communications in chemical pathology and pharmacology. ,vol. 17, pp. 595- 603 ,(1977)
B. A. Berkowitz, S. H. Ngai, J. C. Yang, J. Hempstead, S. Spector, The disposition of morphine in surgical patients Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 629- 635 ,(1975) , 10.1002/CPT1975176629